Richard Whitley to Ganciclovir
This is a "connection" page, showing publications Richard Whitley has written about Ganciclovir.
Connection Strength
1.711
-
Treatment of congenital cytomegalovirus infection: implications for future therapeutic strategies. J Antimicrob Chemother. 2009 May; 63(5):862-7.
Score: 0.343
-
Congenital Cytomegalovirus and Neonatal Herpes Simplex Virus Infections: To Treat or Not to Treat? Pediatr Infect Dis J. 2019 06; 38(6S Suppl 1):S60-S63.
Score: 0.174
-
Cytomegalovirus retinitis--evolving therapies in a new era. N Engl J Med. 1999 Apr 08; 340(14):1109-10.
Score: 0.172
-
Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1997 May; 175(5):1080-6.
Score: 0.151
-
A method for detection of HHV-6 antigens and its use for evaluating antiviral drugs. J Virol Methods. 1996 Apr 26; 58(1-2):137-43.
Score: 0.140
-
Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med. 2015 Mar 05; 372(10):933-43.
Score: 0.130
-
The use of antiviral drugs during the neonatal period. Clin Perinatol. 2012 Mar; 39(1):69-81.
Score: 0.104
-
Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009 Dec; 46 Suppl 4:S22-6.
Score: 0.089
-
Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis. 2008 Mar 15; 197(6):836-45.
Score: 0.080
-
Ganciclovir population pharmacokinetics in neonates following intravenous administration of ganciclovir and oral administration of a liquid valganciclovir formulation. Clin Pharmacol Ther. 2007 Jun; 81(6):867-72.
Score: 0.075
-
Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003 Jul; 143(1):16-25.
Score: 0.058
-
Use of the ganciclovir implant for the treatment of cytomegalovirus retinitis in the era of potent antiretroviral therapy: recommendations of the International AIDS Society-USA panel. Am J Ophthalmol. 1999 Mar; 127(3):329-39.
Score: 0.043
-
Guidelines for the treatment of cytomegalovirus diseases in patients with AIDS in the era of potent antiretroviral therapy: recommendations of an international panel. International AIDS Society-USA. Arch Intern Med. 1998 May 11; 158(9):957-69.
Score: 0.040
-
Population pharmacokinetics of ganciclovir in newborns with congenital cytomegalovirus infections. NIAID Collaborative Antiviral Study Group. Antimicrob Agents Chemother. 1996 Sep; 40(9):2202-5.
Score: 0.036
-
Comparison of genetically engineered herpes simplex viruses for the treatment of brain tumors in a scid mouse model of human malignant glioma. Proc Natl Acad Sci U S A. 1995 Feb 28; 92(5):1411-5.
Score: 0.032
-
Ganciclovir--have we established clinical value in the treatment of cytomegalovirus infections? Ann Intern Med. 1988 Mar; 108(3):452-4.
Score: 0.020
-
Detection of cytomegalovirus (CMV) DNA by polymerase chain reaction is associated with hearing loss in newborns with symptomatic congenital CMV infection involving the central nervous system. J Infect Dis. 2005 Jan 15; 191(2):227-33.
Score: 0.016
-
A rapid protein A binding radioimmunoassay for the evaluation of antiviral agents. J Virol Methods. 1994 Jul; 48(2-3):273-9.
Score: 0.008